There in lies the problem with OTC if the company feels like reporting they can. ELTP wants to be transparent. Good thing too. That's what makes the OTC the wild west of trading companies can do what ever they want.
A company's obligation is to increase the PPS. Not to sit quite and watch the stock just flounder from .97 to .32. Unreal and disappointed as I truly believed all that the CEO stated. I bought the stock based on promises. The two big companies that were courting Elite. The great valuations that were provided. The potential of a Hong Kong deal. Launching ELI in 2014 as stated. Not having a small bunion trial add on a year. Telling us that they negotiated a FDA fee waiver yet all small companies get the first filing free. Watching people dump millions of shares ( JT).
News 
Market Data 
Discover 
AI
